Introduction {#s1}
============

Transient receptor potential (TRP) channels constitute a large superfamily of ion channels that can be grouped in seven subfamilies: TRPC, TRPM, TRPML, TRPP, TRPV, TRPA and TRPN ([@bib41]). The channels of the TRP superfamily are diverse in respect to modes of activities, ion selectivity and physiological functions. Most TRP channels are non-selective cation channels with varying preferences for Ca^2+^ over Na^+^ ([@bib47]). Some TRPs are physically stimulated or voltage-activated, whereas others respond to the binding of ligands or the direct interaction with other proteins. Corresponding to their functional diversity TRPs are involved in many cellular processes, including mechanosensation, thermosensitivity, nociception and store-operated Ca^2+^ entry ([@bib43]).

TRPC4 is one of seven members of the subfamily of TRPC (canonical TRPs) channels ([@bib15]). TRPC channels are Ca^2+^/Na^+^-permeable cation channels that are expressed in many cell types and tissues, including brain, placenta, adrenal gland, retina endothelia, testis, and kidney ([@bib15]). The channels play an important role in vasorelaxation and neurotransmitter release. TRPC4 contributes to axonal regeneration after nerve injury ([@bib74]) and TRPC channels in general are necessary mediators of pathologic cardiac hypertrophy ([@bib75]).

The activation mechanism of TRPC4 has been controversially discussed ([@bib51]). Dependent on the cellular environment and method of measurement, the reported activation mechanism, permeability and biophysical properties differ for TRPC4 and its close homologue TRPC5 ([@bib51]). Several studies showed that TRPC4 and TRPC5 form receptor-operated, Ca^2+^-permeable, non-selective cation channels ([@bib46]; [@bib54]). Others found that TRPC4 and TRPC5 are activated by Ca^2+^ store-depletion with moderate to high Ca^2+^ permeabilities ([@bib50]; [@bib70]). In line with both findings, TRPC4 directly interacts with IP~3~ receptors, calmodulin ([@bib38]; [@bib65]), STIM1 ([@bib31]; [@bib80]), the lipid-binding protein SESTD1 ([@bib40]) and the G protein G~αi2~ ([@bib26]). SESTD1 binds several phospholipid species and is essential for efficient receptor-mediated activation of TRPC5 ([@bib40]). In addition, TRPC channels have been shown to be activated by NO ([@bib78]).

Recently, (-)-Englerin A has been shown to be a potent and selective activator of TRPC4 and TRPC5 calcium channels ([@bib2]). It selectively kills renal cancer cells by elevated Ca^2+^ influx. (-)-Englerin A is so far the only known potent activator of TRPC4 and TRPC5.

The resolution revolution in cryo-EM ([@bib29]) brought an enormous amount of high-resolution structures of TRP channels in the last 5 years ([@bib36]). The cryo-EM structure of TRPV1 ([@bib32]) ushered structural biology of TRP channels in a new era. So far structure models for 48 TRP channels from six subfamilies have been published ([@bib36]). The TRPCs represent the only subfamily for which no high-resolution structure has been reported so far limiting our understanding of these important types of cation channels. Here, we present the first cryo-EM structure of zebrafish TRPC4 in its unliganded (apo), closed state.

Results and discussion {#s2}
======================

Initially, we planned to heterologously express human TRPC4 in HEK293 cells and purify it to determine its structure by single particle cryo-EM. However, the protein proved not to be stable enough for structural investigations. We therefore screened TRPC4 orthologues from several different species and found wild type TRPC4 from zebrafish (TRPC4~DR~) to be the most suitable for our studies. TRPC4~DR~ has very high sequence similarity to human TRPC4 (76% sequence identity, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

To determine whether TRPC4~DR~ has the same channel properties as human TRPC4, we performed voltage-clamp experiments with HEK293 cells heterologously expressing TRPC4~DR~. The measurements demonstrated that, like human TRPC4 ([@bib2]), TRPC4~DR~ can be activated by (-)-Englerin A resulting in similar currents ([Figure 1](#fig1){ref-type="fig"}). Of note, current-voltage curves (IV-curves) in the presence of (-)-Englerin A showed a doubly rectifying form ([Figure 1e](#fig1){ref-type="fig"}) and reversal potentials close to 0 mV (−3.2 ± 1.7 mV, n = 6). The doubly rectifying form of the IV-curve is a characteristic hallmark of active TRPC4 ([@bib2]; [@bib15]; [@bib54]). Under the experimental conditions, namely asymmetric ion concentrations, reversal potentials close to 0 mV indicate a poor cation selectivity, which is a known property of several TRPC4 variants from different species ([@bib15]; [@bib55]).

![Activation of TRPC4~DR~ by the selective activator (-)-Englerin A.\
(**a--f**) HEK293 cells heterologously expressing TRPC4~DR~-EGFP (**a,c,e**) and untransfected control cells (**b,d,f**) were investigated by voltage-clamp experiments in the whole-cell configuration. The membrane potentials were clamped to values ranging from −90 to +90 mV in the absence (**a,b**) and in the presence (**c,d**) of 50 nM (-)-Englerin A. Upon addition of 50 nM of (-)-Englerin A, the current density at −60 mV increased from −3.1 ± 1.9 pA/pF (n = 6) to −16.7 ± 10.7 pA/pF (n = 6). In untransfected control cells, the current density in the absence and presence of the activator was virtually the same with values of −2.1 ± 1.2 pA/pF (V = - 60 mV, n = 5) and −1.8 ± 0.9 pA/pF (V = −60 mV, n = 5) respectively. (**e,f**) Current-voltage curves in the absence (black squares) and in the presence (red circles) of 50 nM (-)-Englerin A. Currents were normalized to the current value in the absence of (-)-Englerin A at a membrane potential of +80 mV. Note that the measurements in the absence and in the presence of (-)-Englerin A were performed on the same cells. Shown are the normalized mean currents of 6 (**e**) and 5 (**f**) different cells. Error bars are ± SEM. The measurements were performed as described in Materials and methods.](elife-36615-fig1){#fig1}

We overexpressed Strep-tagged TRPC4~DR~ in HEK293, solubilized it in n-dodecyl-β-d-maltopyranoside (DDM)/cholesteryl hemisuccinate (CHS) and purified it using affinity and size exclusion chromatography ([Figure 2---figure supplement 1a--b](#fig2s1){ref-type="fig"}). After purification the detergent was exchanged against amphipols. The resulting sample was homogeneous and suitable for structural studies (see Materials and methods, [Figure 2---figure supplement 1c--e](#fig2s1){ref-type="fig"}). We then solved the structure of TRPC4~DR~ in its unliganded (apo), closed state by cryo-EM and single-particle analysis (see Materials and methods) at an average resolution of 3.6 Å ([Figure 2a](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"}, [Figure 2---figure supplements 2](#fig2s2){ref-type="fig"}--[4](#fig2s4){ref-type="fig"}, [Video 1](#video1){ref-type="video"}). The high quality of the map allowed us to build a model of 70% of TRPC4~DR ~de novo. The final model contains residues 18--753 with some loops missing ([Figure 2b](#fig2){ref-type="fig"}). As in most other TRP structures the C-terminal region (residues 754--915) could not be resolved indicating that this region is highly flexible.

![Structure of TRPC4~DR~.\
(**a**) Cryo-EM density map of TRPC4~DR~ with each protomer colored differently and shown as side, bottom and bottom view. (**b**) Ribbon representation of the atomic model of TRPC4~DR~. Colors are the same as in (**a**). (**c**) Topology diagram depicting the domain organization of a TRPC4~DR~ protomer. (**d**) Ribbon representation of a TRPC4~DR~ protomer. Each domain is shown in a different color and labeled accordingly.](elife-36615-fig2){#fig2}
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###### EM data collection and refinement statistics of TRPC4~DR~

  Data collection                   Data set 1 \[Data set 2\]
  --------------------------------- ----------------------------------
  Microscope                        Titan Krios (Cs corrected, XFEG)
  Voltage (kV)                      300
  Camera                            K2 summit (Gatan)
  Pixel size (Å)                    1.09 \[1.09\]
  Number of frames                  60 \[40\]
  Total electron dose (e^-^/Å^2^)   69 \[74\]
  Number of particles               132,622
  Estimated defocus range           0.844--2.931
  Atomic model composition          
  Non-hydrogen atoms                21,412
  Protein atoms                     21,192
  Ligand atoms                      236
  Refinement (Phenix)               
  RMSD bond                         0.01
  RMSD angle                        1.11
  Model to map fit, CC mask         0.80
  Resolution (FSC\@0.143, Å)        3.6
  Map sharpening B-factor (Å^2^)    −130.0
  Validation                        
  Clashscore                        3.53
  Poor rotamers (%)                 0.17
  Favoured rotamers (%)             94.48
  Ramachandran outliers (%)         0.0
  Ramachandran favoured (%)         92.38
  Molprobity score                  1.62
  EMRinger score                    2.42

###### Overview of the TRPC4~DR~ structure

10.7554/eLife.36615.011

The overall structure of the homotetrameric TRPC4~DR~ is similar to that of other TRP channels ([Figure 2a--b](#fig2){ref-type="fig"}). Especially the transmembrane domain comprising the voltage-sensor-like (VSL) domain and pore domain is structurally conserved. Like TRPVs, TRPMs, TRPAs and TRPNs, TRPC4~DR~ does not have extracellular but extended cytoplasmic domains. The resolved regions of the cytoplasmic domain of TRPC4~DR~ reaches \~80 Å into the cytosol and is relatively short compared to other TRP channels. The cytoplasmic domain can be separated in an upper and lower part. The upper part comprises a conserved TRP domain, a pre-S1 elbow domain that enters partially the membrane and an extended helical linker domain ([Figure 2c--d](#fig2){ref-type="fig"}). The lower part is formed by the Rib (or Stretcher) helix, the C-terminal helix and four ankyrin repeats ([Figure 2c--d](#fig2){ref-type="fig"}). 3-D classification and refinement of the final data set ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}) revealed that the lower cytoplasmic part of TRPC4~DR~ is flexible, whereas the transmembrane domain is not ([Video 2](#video2){ref-type="video"}).

###### Morph between conformational states of TRPC4~DR~

10.7554/eLife.36615.012

Voltage-sensor like domain and ion conducting pore {#s2-1}
--------------------------------------------------

Although TRP channels contain a structurally conserved VSL domain comprising four helices (S1-S4), only some members of the TRP family, such as TRPM8, TRPM4, and TRPP1 have been shown to exhibit mild voltage sensitivity ([@bib44]; [@bib59]; [@bib68]). Helix S4 harbors the key residues involved in voltage sensing in voltage-gated ion channels ([@bib64]). A general motif in the voltage-sensing domain (VSD) of voltage-gated ion channels comprises two sets of basic residues on helix S4 that are stabilized by counteracting acidic residues and separated by a hydrophobic patch ([@bib28]). Upon voltage change, helix S4 moves and the positively charged residues jump from one counteracting set of residues over the hydrophobic patch to the next set of negatively charged residues ([@bib81]).

Comparing the VSL domain in our structure and other TRP channels with the VSD in the structure of the Kv1.2-Kv2.1 paddle chimera ([@bib35]), we found that R491 in TRPC4~DR~ is located at the same position as K302 in the potassium channel, corresponding to the lower pair of electrostatically interacting residues ([Figure 3a](#fig3){ref-type="fig"}). At this position an arginine has been observed in TRPM4 and TRPM8 ([@bib73]; [@bib77]), and a lysine in TRPP1 ([@bib60]) ([Figure 3a](#fig3){ref-type="fig"}). In all cases, the basic residues are stabilized by interaction with acidic residues. Importantly, there are no equivalently interacting residues in TRPV1 at this position ([@bib32]) ([Figure 3a](#fig3){ref-type="fig"}). The hydrophobic patch that has been shown to maintain the electric field across the membrane by preventing the movement of ions ([@bib30]) is more prominent in all compared TRP channels than in the Kv1.2-Kv2.1 paddle chimera ([Figure 3a](#fig3){ref-type="fig"}). However, the second pair of interacting basic and acidic residues, which is essential for the movement of helix S4 comprising residues R290, R293, E183 and E226 in Kv1.2, cannot be found in the TRP channels. Only TRPM8 has two residues with complementary charges at this position, however, these residues point away from each other in the structure and do not interact ([@bib77]) ([Figure 3a](#fig3){ref-type="fig"}). Thus, the mechanism of voltage gating in TRP channels must differ from that of voltage-gated ion channels.

![Comparison of the VSL domain of selected TRP family members with the voltage-sensing domain of the chimeric K~V~1.2-K~V~2.1 channel.\
(**a**) The voltage-sensing domain of the chimeric K~V~1.2-K~V~2.1 channel and the VSL domains of TRPC4~DR~,TRPP1, TRPM4, TRPM8 and TRPV1 are shown in ribbon representation. The S4 helix in each case is highlighted with dark shaded color. The rest of the domains are shown in light transparent color. The residues which form the hydrophobic patch in the middle of the domain are shown in golden yellow sphere representation with light transparency. The residues involved in ion-pair interactions are shown in stick representation. (**b**) The structures in (**a**) are rotated to better view the residues important for voltage sensing in the S4 helix of the chimeric K~V~1.2-K~V~2.1 channel and topological equivalent residues of TRP channels are shown in stick representation and labeled.](elife-36615-fig3){#fig3}

Interestingly, positively charged residues that are involved in voltage sensing in Kv1.2, such as R293, R296, R299, R302, R305, and K308 are replaced by polar residues, including N485, S488, S494, and T497 in TRPC4~DR~. The VSL domain in other TRP channels contains more hydrophobic residues ([@bib32]; [@bib73]) ([Figure 3b](#fig3){ref-type="fig"}).

Upstream of the VSL domain resides the pre-S1 elbow domain. It sits inside the membrane and forms a cavity with helices S1 and S4 in which we could identify density corresponding to a sterol ([Figure 4a--b](#fig4){ref-type="fig"}). Since we added CHS during the purification of TRPC4~DR~, we fitted this molecule into the density. Interestingly, a CHS molecule has also been found at the same position in the structures of TRPM4 ([@bib4]) and TRPML3 ([@bib23]). In a second cavity between the pre-S1 elbow domain and helices S1 and S2 resides a proline-rich repeat connecting the TRP and helical linker domains (see below).

![Lipid binding sites in the TRPC4~DR~ structure.\
(**a**) Side and top view of the TRPC4~DR~ structure with lipid densities highlighted in yellow against the model shown in ribbon representation. (**b--c**) Zoomed-in view on the cholesteryl hemisuccinate (CHS) and phosphatidic acid lipid (PA) binding sites, respectively. CHS and PA molecules are shown in yellow stick representation.](elife-36615-fig4){#fig4}

The activation of TRPC4 and TRPC5 is dependent on Ca^2+^ ([@bib51]). However, so far no Ca^2+^ binding sites have been described for TRPCs and we do not have Ca^2+^ in our sample buffer. Interestingly, the four coordinating residues that have been reported for binding of Ca^2+^ in Ca^2+^-activated TRPM4 ([@bib4]) are conserved in TRPC4 ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). In the TRPC4~DR~ structure, their position is very similar to TRPM4 and would allow the coordination of a Ca^2+^ ion ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). Although we indeed observed an extra density at the center between these residues, we did not assign it to Ca^2+^ because of the limited resolution ([Figure 2---figure supplement 4d](#fig2s4){ref-type="fig"}).

Like in other TRP channels, helix S5 and S6 swap over to the respective helices of the adjacent protomer and form the pore at the center of the tetrameric channel ([Figure 2b](#fig2){ref-type="fig"}). The extracellular opening of the pore is negatively charged ([Figure 5a](#fig5){ref-type="fig"}) and the residue E555 at the tip of the pore turret, which is conserved in TRPC1, TRPC4, and TRPC5 ([@bib34]), forms a salt bridge with R556 of the adjacent protomer ([Figure 2---figure supplement 5a--b](#fig2s5){ref-type="fig"}). This results in a positioning of E555 away from the pore and in a relatively wide opening of its entrance similar to TRPV1 ([@bib32]) ([Figure 5b--d](#fig5){ref-type="fig"}). This is in contrast to the narrow pore openings of the more selective Ca^2+^ channels TRPV5 ([@bib24]) and TRPV6 ([@bib37]) and possibly explains the lower selectivity of TRPC4 channels. Mutation of E555 (E559 in TRPC1) to lysine results in decreased store-operated Ca^2+^ influx ([@bib34]), suggesting that a negatively charged and stable pore opening is crucial for the undisturbed permeation of cations through TRPCs.

![Architecture of the pore domain.\
(**a**) Surface electrostatic Coulomb potential at the extracellular mouth of TRPC4~DR~. (**b**) Hydrophobic surface of the pore shown in vertical cross section. Hydrophobic patches are colored orange. (**c**) Ion conduction pore of TRPC4~DR~ shown with diagonally facing protomers shown in ribbon representation. Critical residues important for gating and selection are shown in stick representation. (**d**) Pore radius determined along the pore axis using HOLE ([@bib62]).](elife-36615-fig5){#fig5}

The selectivity filter is formed by four glycine residues (G577) that constrict the pore to a diameter of 7.0 Å (3.7 Å defined by opposing van der Waals surfaces) ([Figure 5c--d](#fig5){ref-type="fig"}). Since the diameters of Na^+^ and Ca^2+^ ions are \~2 Å in their dehydrated and \~10--12 Å in their fully hydrated state, the cations are likely partly dehydrated when passing through the selectivity filter. Although TRPs differ in their cation selectivity, there is no clear factor recognizable that determines the level of selectivity ([Table 2](#table2){ref-type="table"}). Neither the diameter of the filter, ranging from 1.8 to 8.4 Å, nor the type of residue, mostly glycine or aspartate, correlates with the selectivity of the channels for Na^+^ or Ca^2+^ ([Table 2](#table2){ref-type="table"}). The level of selectivity must therefore be defined differently.

10.7554/eLife.36615.016

###### Comparison of selectivity filters among TRP family members

  -------------------------------------------------------------------------------------------------------
  TRP family name   Residue       Van der waals diameter (Å)   Selectivity\*\                Reference
                                                               PCa: PNa                      
  ----------------- ------------- ---------------------------- ----------------------------- ------------
  TRPC4~DR~         G577          3.7                          7                             

  TRPV1             G643          1.5                          3.8--9.6                      ([@bib32])

  TRPV2             Gly604\       1.9\                         3                             ([@bib85])
                    (M606)        (1.35)                                                     

  TRPML3            G457\         2.0\                         Highly selective for Ca^2+^   ([@bib83])
                    (D459)        (4.2)                                                      

  TRPML1            G470 (D471)   1.4\                         N.D.                          ([@bib57])
                                  (2.1)                                                      

  TRPN (NOMPC)      G1506         3.8                          N.D.                          ([@bib27])

  TRPA1             D915          3.2                          0.8                           ([@bib48])

  TRPV5             D542          2.6                          \>100                         ([@bib24])

  TRPV6             D541          0.9                          \>100                         ([@bib53])

  TRPM4             G972          4.3                          PNa: PCa \> 100               ([@bib20])

  TRPP1 (PKD2)      Leu641\       1.7\                         PNa: PCa \> 100               ([@bib59])
                    (Gly642)      (3.6)                                                      
  -------------------------------------------------------------------------------------------------------

\*([@bib67]).

Directly above the selectivity filter resides S580 ([Figure 5c--d](#fig5){ref-type="fig"}) which is replaced by an asparagine residue in human TRPC4 and TRPC5 ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). In TRPC5 this residue has been shown to be important for Ca^2+^ permeability ([@bib11]) and in TRPV1 D646, located at a similar position, has been identified as important residue for cation selection ([@bib17]).

The lumen of the pore below the selectivity filter is mainly hydrophobic ([Figure 5b](#fig5){ref-type="fig"}) and leads to the lower gate at the cytoplasmic end formed by the conserved residues I617 and N621 ([Figure 5c](#fig5){ref-type="fig"}). I617 belongs to the M3 motif found in all TRPCs, TRPVs, and TRPMs ([@bib15]). In our case, the TRPC4~DR~ channel is almost completely closed. The four isoleucines and four asparagines constrict the pore to a diameter of \~5.3 and \~4.2 Å, respectively (1.6 and 0.7 Å defined by opposing van der Waals surfaces) ([Figure 5c--d](#fig5){ref-type="fig"}). Ca^2+^ and Na^+^ ions are too large to fit through these constrictions even in a dehydrated state. The lower constriction of the TRPP channel PKD2 is also formed by an asparagine and leads to a closure of the pore ([@bib60]). Below the asparagine and very close to the cytoplasmic end of the pore, a glutamine (Q625) points towards the pore ([Figure 5c](#fig5){ref-type="fig"}). This residue is conserved in all TRPCs ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), however, its significance has remained unknown.

An important region inside the pore domain is the LFW motif (residues 571--573), which is also conserved in TRPC1 and TRPC5. In TRPC5, mutation of the LFW motif to AAA results in non-functional but folded channels ([@bib63]). In our TrpC4~DR~ structure F572 and W573 form part of a prominent hydrophobic contact between the pore helix of one protomer and helix S6 of the adjacent protomer, stabilizing the pore ([Figure 2---figure supplement 5c--d](#fig2s5){ref-type="fig"}). The triple AAA mutation in this region likely destabilizes this interaction and results in the collapse of the pore explaining the inactivity of the channel. Interestingly, we found an additional density corresponding to an annular lipid at this interface ([Figure 4a,c](#fig4){ref-type="fig"}). The shape of the density clearly corresponds to phosphatidic acid (PA) or ceramide-1 phosphate. Since PA has been assigned to a similar density found in polycytin-2 ([@bib72]) and PA has been included in our purification buffer we fitted PA into the density ([Figure 4c](#fig4){ref-type="fig"}). The phosphate head group interacts with the peptide backbone nitrogen and the polar side chains of T599 of helix S6 and the side chain amino and amide groups of W573 and Q569 of the pore helix, respectively ([Figure 4c](#fig4){ref-type="fig"}). The non-polar tail group is stabilized by interaction with multiple hydrophobic residues from the surrounding helices S5, S6 and the pore helix ([Figure 4c](#fig4){ref-type="fig"}).

Another well-studied region of the pore domain contains two cysteines (C549 and C554). Yoshida et al. showed that S-nitrosylation of these residues in TRPC5 leads to the activation of the channel ([@bib78]). The authors proposed that the modification of the residues has a direct effect on the conformation of helix S6, resulting in the opening of the gate. In the TRPC4 structure, however, C549 and C554 do not locate in close proximity to helix S6 ([Figure 2---figure supplement 5a--b](#fig2s5){ref-type="fig"}). We can therefore exclude a direct interaction. The cysteines form a disulfide bridge in TRPC4~DR~ ([Figure 2---figure supplement 5a--b](#fig2s5){ref-type="fig"}) and are likely involved in putting E555 in place, which is located at the extracellular vestibule above the selectivity filter (see above). Nitrosylation, that reduces the disulphide bond of cystines ([@bib78]) could thus lead to a destabilization of the upper region of the selectivity filter. In this process, E555 could be released and orient towards the center of the pore, altering its properties. Thus, the conformational change could result in a negatively charged sink at the turret, thereby attracting cations, possibly explaining the effect of the increased Ca^2+^ conductance observed by Yoshida et al. ([@bib78]).

The TRP domain and helical linker domain {#s2-2}
----------------------------------------

The TRP domain and linker domain connect the transmembrane domain with the lower cytoplasmic domain ([Figure 2c--d](#fig2){ref-type="fig"}). The TRP domain (residues E634 -- N658) resides directly after helix S6 and is sandwiched between the linker and transmembrane domains. It is conserved in all TRP subfamilies except TRPPs and TRPMLs ([@bib36]; [@bib67]). The core of the TRP domain consists of the conserved WKXQR TRP box sequence (residues 635--639). Its central residue W635 has been shown to be of crucial importance for gating of several TRP channels. Its mutation in TRPV3 leads to Olmsted syndrome ([@bib33]) and in NOMPC an exchange to alanine results in a channel with a prominent basal current that does not respond to mechanical stimuli anymore ([@bib27]).

Like in other TRP domain-containing TRPs, W635 in TRPC4~DR~ interacts with the conserved G503 in the adjacent M2 motif (residues 502--511) thereby linking the TRP domain with the linker between helices S4-S5 ([Figure 6a--b](#fig6){ref-type="fig"}). G503 is conserved in all TRP subfamilies containing a TRP domain ([Figure 6c](#fig6){ref-type="fig"}). Mutation of this residue to serine in TRPC4 and TRPC5 forces the channels in an open conformation ([@bib6]). The proper interaction between G503 and W635 guarantees the stabilization of helix S6 that forms the lower gate of the pore. It becomes clear from looking at these residues in our TRPC4~DR~ structure, that a G503S or W635A mutation would impair the interaction at this site and result in the loss of control over the gate ([Figure 6b](#fig6){ref-type="fig"}).

![Interaction of the TRP domain with a conserved glycine in the S4-S5 linker.\
(**a**) Ribbon overview indicating the interaction site between the TRP domain and the S4-S5 linker. Key helices are shown in different colors. The rest of the protein is shown in light grey. (**b**) Zoomed-in view on the interaction site with key residues labeled. The chain trace is shown in stick representation. (**c**) Structure-based sequence alignment of TRP family members. The conserved glycine in the M2 motif is highlighted by a red dotted box.](elife-36615-fig6){#fig6}

E648 and E649 which are conserved in TRPC4 and TRPC5 ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) are located at a peripheral loop of the TRP domain ([Figure 7a](#fig7){ref-type="fig"}). The glutamates interact electrostatically with two lysine residues (K684 and K685) in Stim1 proteins resulting in the activation of cation currents ([@bib31]; [@bib80]). In line with this biochemical finding, E648 and E649 (E649 is not resolved in our structure) are exposed at the periphery of TRPC4~DR~ ([Figure 7a](#fig7){ref-type="fig"}) and are accessible for interactions with other proteins.

![Position of the Rib helix in TRPC4~DR~ and TRPM4.\
(**a-b**) Side and bottom view of the atomic models of TRPC4~DR~ (**a**), and TRPM4 (**b**). The Rib helix is highlighted in blue color and the density of the map is shown in the background with high transparency. E648 in TRPC4~DR~ is shown in sphere representation and colored red.](elife-36615-fig7){#fig7}

TRPC4~DR~ contains two conserved proline-rich regions downstream of the TRP domain. Proline-rich regions are often involved in specific protein--protein interactions and signal transmission. In TRPC4~DR~ the first proline-rich region formed by P654, P655, P656 re-enters the membrane and is sandwiched between the pre-S1 elbow domain and helix S2 making it inaccessible from the cytoplasm or the membrane. The second proline-rich region around the residues P661 and P663 is not resolved in our structure but this region is located at the outside of the protein and could thereby be accessible for interacting with regulatory proteins like Homer. Homer is an adaptor protein that facilitates the physical interaction between TRPC1 and the IP~3~ receptor ([@bib79]).

The helical linker domain is made of three layers of helices that are arranged like stair steps and a coil of shorter helices ([Figure 2d](#fig2){ref-type="fig"}). The upper layer of helices harbors the M1 motif (residues 285--319), which is conserved in the TRPC family ([@bib14]). The central two helices form a short coiled-coil structure that harbors the multimerization motif (residues D254 -Q302), that has been predicted to be involved in the multimerization of TRPCs ([@bib15]). Indeed, in contrast to other TRP family members ([@bib36]), the helical linker domain does not only connect the transmembrane domain with the lower cytoplasmic domain but also strongly interacts with the adjacent linker domains thereby stabilizing the tetramer ([Figure 2a--b](#fig2){ref-type="fig"}). This kind of interaction has not been observed in the structures of other TRP subfamily members, such as TRPA1 ([@bib48]), NOMPC ([@bib27]) and TRPM4 ([@bib4]; [@bib20]; [@bib73]). In the TRPV subfamily, the cytoplasmic inter-protomer interaction is mediated between the ankyrin repeat domain of one protomer and the β-strand linker domain of the adjacent protomer ([@bib32]).

The lower part of the cytoplasmic domain {#s2-3}
----------------------------------------

Ankyrin repeats, the Rib helix, and C-terminal helix domain constitute the most distant region of TRPC4~DR~ ([Figure 2c--d](#fig2){ref-type="fig"}). Ankyrin repeats, that are often involved in protein-protein interactions ([@bib58]), are abundant in TRP channels in varying numbers, ranging from 0 in TRPP ([@bib60]) and TRPML ([@bib9]; [@bib23]; [@bib57]; [@bib83]) to 29 in NOMPC ([@bib27]). In most structures of TRPs the first ankyrin repeats are oriented in a parallel fashion like in TRPA1 ([@bib48]) ([Figure 8a](#fig8){ref-type="fig"}). TRPCs contain four ankyrin repeats in the cytoplasmic domain. Biochemical studies have shown that at least the first ankyrin repeat is necessary in TRPC5 for proper tetramerization and function of the channel ([@bib56]). In the structure of TRPC4~DR~ the repeats take a unique twisted orientation and swap over to an adjacent protomer interacting with the C-terminal helix domain and Rib domain explaining the ankyrin repeat's stabilizing effect on the tetramer ([Figures 2b](#fig2){ref-type="fig"} and [8b](#fig8){ref-type="fig"}).

![Comparison of the ankyrin domain arrangement of TRPC4~DR~ and TRPA1.\
(**a-b**) Side and bottom view of the structures of TRPA1 (PDB-ID: 3J9P) (**a**) and TRPC4~DR~ (**b**) in surface representation. Each subunit is colored with unique colors. (**c--d**) Ribbon and cartoon representation of TRPA1 (**c**) and TRPC4~DR~ (**d**) showing two protomers in side view. The ankyrin repeats of one protomer are highlighted in brown.](elife-36615-fig8){#fig8}

The Rib helix runs almost parallel to the membrane and protrudes from the cytoplasmic domain ([Figure 7a](#fig7){ref-type="fig"}). It contains a dual calmodulin- and IP~3~ receptor-binding site (CIRB) ([@bib38]; [@bib65]) and has been described as binding hub not only for these proteins but also for SESTD1 ([@bib40]) and the G protein G~αi2~ ([@bib26]) ([@bib84]). It is therefore a central interaction site for TRPC4-modulating proteins and the activity of the channel might be modulated by a displacement mechanism in which the different modulators compete for the same binding site ([@bib84]). A homologous helix has been observed in the structure of TRPM4 ([@bib4]; [@bib20]; [@bib73]). However, in the structure of TRPM4 the Rib helix is buried by other domains and only the very tip is accessible from the surface ([Figure 7b](#fig7){ref-type="fig"}). The Rib helix of TRPC4~DR~, however, is accessible from the cytoplasm and direct binding of calmodulin or IP~3~-receptor is possible ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}).

A second major protein interaction hub is the C-terminal helix domain. It has only been observed before in TRPA1 ([@bib48]), TRPM4 ([@bib4]) ([@bib21]; [@bib73]), and TRPM8 ([@bib77]). In all described structures, it has a coiled-coil structure ([Figure 9a--b](#fig9){ref-type="fig"}). In the case of TRPC4~DR~, however, the helices run in a parallel fashion ([Figure 9c](#fig9){ref-type="fig"}). The C-terminal helix domain has been shown to bind to the D~2~ dopamine receptor ([@bib22]) and spectrin αII and βV which are involved in surface expression and activation of TRPC4 ([@bib45]).

![Comparison of the C-terminal helix architecture in TRPA1, TRPM4 and TRPC4~DR~.\
(**a-c**) Each panel shows the complete tetramer in bottom and side view on the left and the zoomed-in view of the C-terminal helix alone in bottom and side view on the right. The C-terminal helix is shown in blue with one helix highlighted in shaded dark blue.](elife-36615-fig9){#fig9}

Our structure of TRPC4 misses 162 residues at the C-terminus. This part of the protein comprises a PDZ-binding domain ([@bib39]) and a second IP~3~-binding domain ([@bib38]) and calmodulin binding sites ([@bib65]; [@bib66]). Interestingly, the largest part of this region is missing in the second most abundant splice variant of TRPC4, namely TRPC4β ([@bib15]). In line with our structural data, a sequence-based structure prediction using PSIPRED ([@bib8]) indicates that this region has no defined secondary structure.

In summary, the results allow us to understand the three-dimensional organization of TRPC channels. The structure of TRPC4~DR~ reveals how the ion conduction pathway is built and our results point towards a gating mechanism that is conserved in all type I TRP channels. Future studies will be needed to structurally understand how TRPCs are activated or in general modulated by proteins and other factors and permeate cations. Our structure-based localization of previously biochemically identified protein binding sites provides the structural framework for further experiments towards understanding how binding of regulatory protein affect the structure and function of TRPC4.

Data availability {#s2-4}
-----------------

The atomic coordinates and cryo-EM maps for TRPC4~DR~ are available at the Protein Data Bank (PDB)/Electron Microscopy Data Bank (EMDB) databases. The accession numbers are 6G1K/EMD-4339. The data sets generated in the current study are available from the corresponding author on reasonable request.

Materials and methods {#s3}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\              Designation                                                            Source or reference              Identifiers                             Additional information
  (species) or resource                                                                                                                                                      
  -------------------------- ---------------------------------------------------------------------- -------------------------------- --------------------------------------- --------------------------------------------------------------------------------------------------------------------------------
  Gene (Danio rerio)         TRPC4~DR~                                                              N/A                              NCBI Reference sequence: NM_001289881   Genes ordered from GenScript

  Cell line (HEK293 GnTI-)   HEK293 GnTI-                                                           ATCC                             CRL-3022                                

  Cell line (HEK293)         HEK293                                                                 ATCC                             CRL-1573                                

  Cell line (Sf9)            Sf9                                                                    N/A                              Cat.No.600100                           Purchased from Oxford Expression Technologies Ltd (UK)

  Recombinant DNA reagent    pcDNA3.1+TRPC4~DR~(See Materials and methods section for details)      This paper                                                               Cloned by GenScript in the customized pcDNA3.1 vector harbouring N~term~-HIS~8~tag-TEV- and C~term~-HRV3C-eGFP

  Recombinant DNA reagent    pEG BacMam                                                             Eric Gouaux Lab PMID: 25299155                                           

  Recombinant DNA reagent    pEG BacMam +TRPC4~DR~(See Materials and methods section for details)   This Paper                                                               Subcloned the pcDNA construct harbouring His-TEV- TRPC4- HRV3C -eGFP into the pEG BacMam with the introduction of StrepII tag.

  Chemical compound, drug    (-)Englerin A                                                          N/A                                                                      Obtained from Lead Discovery Center GmbH, Dortmund Germany

  Software, algorithm        SPHIRE software package                                                [@bib42] PMID: 28570515                                                  

  Software, algorithm        CrYOLO                                                                 N/A                                                                      Wagner et al., unpublished. manuscript in preparation

  Software, algorithm        RosettaCM                                                              [@bib69] PMID: 27572730                                                  

  Software, algorithm        Rosetta                                                                [@bib69] PMID: 27572730                                                  

  Software, algorithm        rosettaES                                                              [@bib16] PMID: 28628127                                                  

  Software, algorithm        Chimera                                                                [@bib49] PMID:15264254                                                   
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Protein expression and purification {#s3-1}
-----------------------------------

The full-length (2-915) *Danio rerio* (zebrafish) TRPC4~DR~ (NM_001289881) was cloned into the pEG BacMam vector ([@bib19]), with a C-terminal HRV-3C cleavage site followed by EGFP Twin-StrepII-tag (WSHPQFEKGGGSGGGSGGSAWSHPQFEK) and a N-terminal eight poly-histidine tag followed by a TEV cleavage site. Bacmid and baculovirus were produced as described previously ([@bib19]). In brief, P2 baculovirus produced in Sf9 cells, was added to HEK293 GnTI^-^ cells (mycoplasma test negative, ATCC \#CRL-3022) grown in suspension in FreeStyle medium (GIBCO-Life Technologies \#12338--018) supplemented with 2% FBS at 37°C and 8% CO~2~. Eight hours after transduction, 5 mM sodium butyrate was added to enhance protein expression for additional forty hours and the temperature was reduced to 30°C. After 48-hr post-transduction, cells were harvested by low-speed centrifugation in an Avanti J-20 XP centrifuge (Beckman Coulter) at 8,983 g for 15 min, washed in phosphate-buffered saline (PBS) pH 7.4, and pelleted in an Allegra X-15R (Beckman Coulter) Centrifuge at 4,713 g for 15 min. The cell pellet was resuspended and cells were lysed in an ice-cooled Microfluidizer Mod. 110S (Microfluidics Corporation) in buffer A (PBS buffer pH 7.4, 1 mM Tris(2-carboxyethyl)phosphine (TCEP), 10% glycerol) and protease inhibitors (0.2 mM AEBSF, 0.1 µM aprotonin and 1 µM phosphoramidion); 50 ml was used per pellet obtained from 800 ml of HEK 293 cell culture. Subsequently, the lysate was centrifuged at 15,000 g for 5 min, and the membranes were collected by ultracentrifugation in an Optima XPN-80 ultracentrifuge (Beckman Coulter) equipped with a Type 70 Ti Rotor at 164,700 g for one hour. The membranes were then mechanically homogenized in buffer B (100 mM Tris-HCl pH 8, 150 mM NaCl, 1 mM TCEP, 10% glycerol) and protease inhibitors, quick-frozen and stored at −80°C till further purification. Membranes were solubilized for 2 hr in buffer B supplemented with 1% DDM/0.1% CHS (Anatrace \#D310-CH210). Insoluble material was removed by ultracentrifugation for 1 hr in a Beckman Coulter Type 70 Ti Rotor at 164,700 g. The soluble membrane fraction was diluted 2-fold with buffer B to reduce the detergent concentration and slowly applied to a column packed with Strep-Tactin beads (IBA Lifesciences) by gravity flow (6--10 s/drop) at 4°C. Next, the resin was washed with five column volumes of buffer B supplemented with 0.04% DDM/0.004% CHS solution, 0.02 mg ml^−1^ soy polar lipids (Avanti \#541602) dissolved in DDM and protease inhibitors. Bound protein was eluted seven times with 0.5 column volumes of buffer A with 4 mM d-desthiobiotin (Sigma), 0.026% DDM/0.0026% CHS, 0.02 mg ml^−1^ soy polar lipids and 0.1 mM AEBSF protease inhibitor. The C-terminal EGFP tag was removed by incubating the eluted fractions with HRV-3C protease overnight. The next day, the detergent was replaced with amphipols A8-35 (Anatrace \#A835) by adding four times the total protein mass and incubating for 6 hr at 4°C. Detergent removal was performed by adding Biobeads SM2 (BioRad \# 1523920) pre-equilibrated in PBS to the protein solution at 15 mg ml^−1^ final concentration for 1 hr, then replaced with fresh Biobeads at 20 mg ml^−1^ for overnight incubation at 4°C. Biobeads were removed using a Poly-Prep column (BioRad \#7311550) and the solution was centrifuged at 20,000 g for 10 min to remove any precipitate. The protein was concentrated with a 100 MWCO Amicon centrifugal filter unit (Millipore) and purified by size exclusion chromatography using a Superose 6 10/300 GL column (GE healthcare) equilibrated in buffer C (PBS pH 7.4, 1 mM TCEP). The peak corresponding to tetrameric TRPC4~DR~ in amphipols was collected and concentrated up to 0.3 mg ml^−1^ for both negative stain and cryo-EM analysis.

EM data acquisition {#s3-2}
-------------------

Tetramer TRPC4~DR~ integrity was evaluated by negative stain electron microscopy prior to cryo-EM grid preparation and image acquisition ([@bib18]). In brief, 4 µl of TRPC4~DR~ in amphipols at a concentration of 0.02 mg ml^−1^ were applied onto a freshly glow-discharged copper grid (Agar Scientific; G400C) with an additional thin carbon layer. After an incubation of 45 s, the sample was blotted with Whatman no. four filter paper and stained with 0.75% uranyl formate. The images were recorded manually with a JEOL JEM-1400 TEM, operated at an acceleration voltage of 120 kV, and a 4,000 × 4,000 CMOS detector F416 (TVIPS) with a pixel size of 1.84 Å/pixel ([Figure 2---figure supplement 1c--e](#fig2s1){ref-type="fig"}). For cryo-EM, 3.5 µl of TRPC4~DR~ at a concentration of 0.25 mg ml^−1^ were applied onto freshly glow-discharged holey carbon grids (Quantifoil grid (1.2/1.3) 300 mesh) blotted using 2.5 s blotting time, 1 s draining time, 0 blotting force with 100% humidity at 4°C and vitrified in liquid ethane cooled by liquid nitrogen using a Vitrobot Mark III (FEI Company). The quality of the grids was screened with a JEOL JEM 3200 FSC electron microscope equipped with a field-emission gun and an in-column energy filter operated at an acceleration voltage of 200 kV. The grids were then stored in liquid nitrogen.

Electron microscopy and single particle cryo-EM data processing {#s3-3}
---------------------------------------------------------------

A cryo-EM data set of TRPC4~DR~ in amphipols was collected on a C~s~-corrected TITAN KRIOS electron microscope (FEI), equipped with a high-brightness field-emission gun (XFEG) operated at an acceleration voltage of 300 kV. The images were acquired on a K2 summit direct electron detector (Gatan) operated in counting mode with a calibrated pixel size of 1.09 Å/pixel on the sample level with a post column GIF BioQuantum LS energy filter (Gatan) using a slit width of 20 eV. Two data sets were collected. The first data set with a total of 2020 images was collected with sixty frames (200 ms/frame) and an exposure of 12 s with a total dose of \~69.0 e^−^ Å^−2^. A second data set with a total of 1870 images was recorded with forty frames (300 ms/frame) and an exposure of 12 s with a total dose of \~74.4 e^-^ Å^−2^. All images were collected automatically using EPU (FEI). Motion correction was performed using the MotionCor2 program ([@bib82]).

All image processing was performed with the SPHIRE software package ([@bib42]) ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Motion-corrected sums without dose weighting were used to determine the defocus and astigmatism in CTER ([@bib42]). The defocus range of the selected images was 0.84--2.93 µm ([Table 1](#table1){ref-type="table"}). Images with low quality were removed using the graphical CTF assessment tool in SPHIRE ([@bib42]). Motion-corrected sums with dose weighting were used for all other image processing steps. 426,377 single particles were picked automatically using CrYOLO (Wagner et al., unpublished). The particles were windowed to a final box size of 224 × 224 pixels. Reference-free 2-D classification and cleaning of the data set was performed with the iterative stable alignment and clustering approach ISAC ([@bib76]) in SPHIRE. ISAC was performed at a pixel size of 3.02 Å/pixel. The 'Beautify' tool of SPHIRE was then applied to obtain refined and sharpened 2-D class averages at the original pixel size, showing high-resolution features ([Figure 2---figure supplement 2a](#fig2s2){ref-type="fig"}). A subset of \~132,622 particles producing 2-D class averages and reconstructions with high-resolution features were then selected for further structure refinement. An initial model for the first 3-D refinement was generated from the ISAC class averages with RVIPER. All 3-D refinements and classifications were performed imposing C4 symmetry. The 'clean' data set after ISAC was then subjected to 3-D refinements in MERIDIEN with a mask including amphiphols ([@bib42]). The final half-maps were combined, a tight mask and a B factor of −130.0 Å^2^ were applied using SPHIRE's PostRefiner tool. This resulted in a cryo-EM map with an average resolution of 3.6 Å, as estimated by the 'gold standard' FSC = 0.143 criterion between the two masked half-maps ([Figure 2---figure supplement 2f](#fig2s2){ref-type="fig"}). The estimated accuracy of rotation and translation during the last iteration of the 3-D refinement were estimated to be 0.9375° and 0.7 pixels, respectively. Local FSC calculation was performed using the 'Local Resolution' tool in SPHIRE. This analysis showed that the core of TRPC4~DR~ was resolved up to 3.1 Å resolution, whereas the upper and peripheral part of the protein showed the lowest resolution (\~4.5--5 Å) ([Figure 2---figure supplement 2e](#fig2s2){ref-type="fig"}). The final density was then locally filtered on the basis of the local resolution with the 'LocalFilter' utility in the SPHIRE software package. Details related to data processing are summarized in [Table 1](#table1){ref-type="table"}.

3-D clustering into six groups was performed using the RSORT3D tool of SPHIRE with a 3-D focused binary mask including the C-terminal helix and the ankyrin repeats. The resulting volumes were refined with the 'local refinement mode' of MERIDIEN in SPHIRE. The SPHIRE 'PostRefiner' tool was used to determine the resolution of the locally refined volumes.

Model building, refinement and validation {#s3-4}
-----------------------------------------

Initially, we built a homology model of TRPC4~DR~ with Modeller ([@bib13]), using the structures of NOMPC (PDB-ID: 5VKQ) and TRPV1(PDB-ID: 3J5Q) as templates. These are the homologs with the highest sequence identity and of which high-resolution structures have been determined. Since only the transmembrane domain could be built using this method we used Rosetta to complete the model. Gaps in the membrane domain were built using RosettaCM ([@bib69]). The rest of the monomer was built de novo using several iterative runs of the fragment fitting protocol implemented in Rosetta ([@bib69]). After this, loops still missing from the model were manually built in Coot ([@bib12]). We generated a tetramer model by fitting four copies of the monomer model into the cryo-EM density using Chimera ([@bib49]). With the tetramer, we built 18 additional amino acids the N-terminal end of the protein using the enumerative sampling strategy in Rosetta (rosettaES) ([@bib16]), which could not be reliably built manually due to the quality of the density in this region. Final manual model building, including fitting of lipids, was done in Coot ([@bib12]). The full model was finally refined in Phenix ([@bib1]) using the real space refinement protocol. The final model comprises residues 18--753 with missing sequence in between 119 and 134, 173 and 186, 273 and 283, 320 and 323, 389, 390, 649 and 651, 661 and 695, 728 and 730. Finally, we used Molprobity ([@bib10]) to validate the overall geometry of the model, Phenix ([@bib1]) to calculate the model-to-map correlation, and EMRinger ([@bib5]) to validate the side chain geometry. The densities corresponding to annular lipids were modelled as phosphatidic acid lipid with a shorter lipid tail (PDB-ID 44E) and CHS (PDB-ID YO1). The geometric restraints for the refinement of both lipids were obtained by the eLBOW module in PHENIX ([@bib1]). Figures were prepared in Chimera ([@bib49]) and VMD ([@bib25]). Structure-based sequence alignment was done using the Multiseq plugin ([@bib52]) in VMD. Multiple sequence alignment was done using Clustal Omega ([@bib61]). Figures of the sequence alignment were made with Jalview ([@bib71]). The radius of the pore was determined using HOLE ([@bib62]). The pK~a~ values of protein residues were calculated using the H++ server ([@bib3]) and used to assign the right protonation states in the calculation of electrostatic potentials in Chimera.

Electrophysiological recordings on HEK293 cells heterologously expressing TRPC4~DR~-EGFP {#s3-5}
----------------------------------------------------------------------------------------

HEK293 cells (ATCC, CRL-1573^TM^, Manassas, USA) were cultured at 37°C and 5% CO~2~ in DMEM (Sigma, St. Louis, USA) supplemented with 10% fetal calf serum (Sigma, St. Louis, USA), and 5% penicillin/streptomycin (Sigma, St. Louis, USA). One day prior to transient transfections the HEK293 cells were seeded on 24-well plates. The transient transfections of the seeded HEK293 cells with pCDNA3.1 carrying TRPC4~DR~-EGFP using Lipofectamine 2000 (Invitrogen, Carlsbad, USA) were performed two days prior to the patch-clamp measurements.

Whole cell patch-clamp experiments on HEK293 cells heterologously expressing TRPC4~DR~-EGFP were performed under voltage clamp conditions using the Axopatch 200B amplifier (Axon Instruments, Union City, USA) and the DigiData 1322A interface (Axon Instruments, Union City, USA). Patch pipettes with resistances of 2--5 mΩ were fabricated from thin-walled borosilicate glass on a horizontal puller (Model P-1000, Sutter Instruments, Novato, USA). The series resistance was \<10 MΩ. The bath solution ([@bib2]) contained 135 mM NaCl, 5 mM KCl, 1.2 mM MgCl~2~, 1.5 mM CaCl~2~, 8 mM glucose, 10 mM HEPES (pH titrated to 7.4 using NaOH) and the pipette solution contained 145 mM CsCl, 2 mM MgCl~2~, 10 mM HEPES, 1 mM EGTA (sodium salt), 0.1 mM GTP (sodium salt, pH titrated to 7.2 with CsOH). For the recordings of the IV-curves the membrane potentials were clamped to values ranging from −90 mV to +90 mV. The measurements were conducted in the absence and in the presence of 50 nM (-)-Englerin A.
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Data availability {#s6}
-----------------

The atomic coordinates and cryo-EM maps for TRPC4DR are available at the Protein Data Bank (PDB)/Electron Microscopy Data Bank (EMDB) databases. The accession numbers are 6G1K/EMD-4339. The raw data sets generated in the current study (motion corrected and dose weighted mrc files and box files; 215 GB) are available from the corresponding author upon request.
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National Institute of Neurological Disorders and Stroke, National Institutes of Health
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Electron cryo-microscopy structure of the canonical TRPC4 ion channel\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Kenton Swartz as the Reviewing Editor and Richard Aldrich as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: László Csanády (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The TRP family of cation channels is comprised of 7 subfamilies with varying numbers of members, all of which exhibit different functional properties, ion selectivity and modulation by various interaction partners and cellular mediators. They are thus involved in a large variety of physiological functions, from sensory stimuli detection to ion homoeostasis in the body, to proper organelle function inside the cell. Mutations in many of these channels have also been directly associated with serious human pathologies. The recent cryo-EM revolution has brought to light the structures of many TRP channels, providing insight into their mechanisms of gating and modulation, and highlighting both the striking similarities and differences between members of the TRP family. So far structures of representatives from each of the TRP channel subfamilies have been obtained except for the TRPC family. TRPC (canonical) channels are widely expressed in the body. The TRPC4 and C5 have been shown to form non-selective Ca^2+^ permeable channels activated upon Ca^2+^-store depletion, and their function is modulated by interaction with important partners such as calmodulin, IP3 receptors and STIM1.

In the present manuscript the authors have solved the first structure of a TRPC channel, the zebra fish TRPC4 in the closed apo state, at an overall resolution of 3.6A using cryo-EM with amphipol-stabilized proteins expressed in HEK cells prior to purification. The map quality allowed for the de novo building of a structural model comprising 70% of the protein. The authors first demonstrate that the zebrafish TRPC4 is functional and can be activated by the agonist (-)-EnglerinA and exhibits similar rectification properties as human TRPC4. Their structure reveals important properties of the channel, with interesting similarities and differences with other TRP channels which allow for inferences on the function and modulation of TRPC channels and TRP channels in general. The tetrameric protein exhibits a domain-swapped architecture for the transmembrane region. The transmembrane domain topology is very similar to the rest of the TRP channels which lack large extracellular domains (i.e. all except TRPP1 and TRPMLs). The structure allows visualization of the ion conduction pathway, revealing interesting residue interactions with functional significance in the outer vestibule, the pore helix and S6 segments, and also demonstrate the existence of an intracellular activation gate within the S6 helix.

Other functionally important interactions between the TRP domain and the M2 motif are also revealed, together with interesting differences between the voltage sensor-like domain of TRPC4 and other related TRP channels such as TRPV1 and M8. Two lipid binding sites are identified, one within the VSL domain/linker domain helix and the other within the upper half of the pore. Interestingly, the authors find that a functionally important Ca^2+^ binding site within the VSL-domain identified in the Ca^2+^-bound TRPM4 structure by Autzen et al. is conserved in TRPC4, suggesting that the Ca^2+^-dependent modulation of this channel, for which no structural correlate had been found to date, might depend on this site. The intracellular domains of TRPC4 are unique and exhibit a two-layered architecture with extensive intra- and inter-subunit contacts that likely contribute to the stability of the tetramer and gating of the receptor. The presence of a protruding C-terminal rib helix known to contain interaction sites for several important TRPC4 modulators, including calmodulin, IP3R, SESTD1 and G proteins, is resolved and shown to be exposed to the cytosol, providing a structural background to investigate the complex regulatory mechanisms of this protein. Overall, the work in the manuscript seems of high quality, and the properties of the structure are discussed with detail, considering both functional observations in TRPC4 and the related TRPC5 channels and the structural information coming from the other TRP channels.

Essential revisions:

1\) In Figure 1, the authors need to include current traces for the non-transfected cells in the absence and presence of agonist. They should also include a normalized mean +/- SEM current-voltage relations for both transfected and un-transfected cells in the absence and presence of the agonist.

2\) The authors seem to imply that the disulfide bond formation/breakage in the extracellular pore loop of TRPM4 is Ca^2+^- and gating-dependent. However, disulfides are strong bonds that would not be expected to break simply from the binding of Ca^2+^ ions to a site very distant from the bond. Autzen et al. mention in their TRPM4 paper that the breakage of the bond in their Ca^2+^-bound structure could have resulted from radiation damage. It is thus necessary to modify that part of the Results/Discussion section in the present manuscript to reflect this. The disulfide formation/breakage might have a role in gating of the TRPC4 channel, but this most likely does not occur as a consequence of agonist binding, but rather by the direct action of oxidizing or reducing agents in the cysteines themselves.

3\) The use of (-)-Englerin A to activate the channel in functional experiments naturally begs the question of whether a structure of activator and TRPC4 in complex could have reasonably been included to add mechanistic richness to the study. This is especially so given that reporting multiple states (when chemical tools exist) is typically straightforward with cryo-EM. If there were experimental challenges that precluded this, or if (-)-Englerin is not a good candidate for mechanistic insight, etc., perhaps the authors could comment on this.

4\) The cryo-EM density map shows unambiguous extra density, which the authors interpreted as CHS and PA. Inspection of the map and model together (at a contour similar to the figures) shows portions of the CHS and PA models fall outside of the density. That said, CHS and PA are sensible candidates to assign to these densities, but given the 3.6 Å resolution of the map, did the authors try or consider trying an orthogonal method to firmly establish the identities of the lipids in the amphipol solubilized protein? For example, Mi and co-workers used mass spectrometry with mutagenesis to reinforce lipid density assignment for their MsbA work (Mi et al. 2017 Nature). We are not requesting new experiments, but it would be nice to know more if the authors have additional information or tried other approaches.

5\) The function of voltage-sensing domains in voltage-activated channels depends not only on the presence of positively charged residues in the S4, but also on the presence of countercharges along the path through which the S4 moves upon activation/deactivation, together with a hydrophobic \"plug\" that focuses the electric field at a point between the intra-and extracellular cavities in which the S4 charges reside. The figures used to illustrate the properties of the VSL-domain of Kv, TRPC4, TRPM4 and TRPV1 channels focuses only on the S4 charges. It may be useful to inspect whether the other VSL-domain helices contain comparable properties as those of voltage-activated channels.

Furthermore, although it is an interesting observation that the S4 of TRPC4 is more hydrophilic than that of e.g. TRPV1, TRPM4 and TRPM8, the voltage-dependence of TRPC4 is rather weak, arguably weaker than that of TRPV1 and TRPM8. Yet, the latter channels are not expected to derive their voltage-dependence from the movement of S4. Thus, we suggest more caution in suggesting that the VSL-domain of TRPC4 might function similarly as that of voltage-gated channels. Finally, the TRPP1 channel seems to also contain a larger number of polar residues in its S4 helix, and exhibits pronounced voltage-dependence, such that it might be interesting to include it in the comparison.

10.7554/eLife.36615.029

Author response

> Essential revisions:
>
> 1\) In Figure 1, the authors need to include current traces for the non-transfected cells in the absence and presence of agonist. They should also include a normalized mean +/- SEM current-voltage relations for both transfected and un-transfected cells in the absence and presence of the agonist.

We have added current traces for the non-transfected cells in the absence and presence of (-)-Englerin A to Figure 1. We also included normalized mean +/- SEM current-voltage relations for both transfected and un-transfected cells in the absence and presence of the agonist.

> 2\) The authors seem to imply that the disulfide bond formation/breakage in the extracellular pore loop of TRPM4 is Ca^2+^- and gating-dependent. However, disulfides are strong bonds that would not be expected to break simply from the binding of Ca^2+^ ions to a site very distant from the bond. Autzen et al. mention in their TRPM4 paper that the breakage of the bond in their Ca^2+^-bound structure could have resulted from radiation damage. It is thus necessary to modify that part of the Results/Discussion section in the present manuscript to reflect this. The disulfide formation/breakage might have a role in gating of the TRPC4 channel, but this most likely does not occur as a consequence of agonist binding, but rather by the direct action of oxidizing or reducing agents in the cysteines themselves.

We apologize for creating confusion. We did not want to claim any Ca^2+^ dependence in connection to the disulphide. This passage was not well worded. We have rephrased this part of the manuscript to make it clearer for the reader.

> 3\) The use of (-)-Englerin A to activate the channel in functional experiments naturally begs the question of whether a structure of activator and TRPC4 in complex could have reasonably been included to add mechanistic richness to the study. This is especially so given that reporting multiple states (when chemical tools exist) is typically straightforward with cryo-EM. If there were experimental challenges that precluded this, or if (-)-Englerin is not a good candidate for mechanistic insight, etc., perhaps the authors could comment on this.

Indeed, we have tried to obtain the structure of TRPC in complex with (-)-Englerin as suggested by the reviewers. However, although we have tried several conditions, so far we have not been successful. Since there is also no experimental evidence that (-)-Englerin binds directly to TRPC4 to activate it, we will now first investigate the interaction of (-)-Englerin with TRPC4 in an in vitro system. However, these studies will take time and go beyond the scope of this manuscript. We believe that our structure of TRPC4 in the apo state gives already enough novel insights to justify publication in *eLife*.

> 4\) The cryo-EM density map shows unambiguous extra density, which the authors interpreted as CHS and PA. Inspection of the map and model together (at a contour similar to the figures) shows portions of the CHS and PA models fall outside of the density. That said, CHS and PA are sensible candidates to assign to these densities, but given the 3.6 Å resolution of the map, did the authors try or consider trying an orthogonal method to firmly establish the identities of the lipids in the amphipol solubilized protein? For example, Mi and co-workers used mass spectrometry with mutagenesis to reinforce lipid density assignment for their MsbA work (Mi et al. 2017 Nature). We are not requesting new experiments, but it would be nice to know more if the authors have additional information or tried other approaches.

Because of its distinguished flat shape one density clearly corresponds to sterol. Because we have included CHS in our purification and CHS has been identified at similar positions in the structures of TRPM4 and TRPML3, we have assigned CHS to it. Although protruding from the density there is enough space in the structure to accommodate the succinyl group of CHS which is likely stabilized by a putative hydrogen bond with Tyr315.

The second lipid density can be clearly assigned to phosphatidic acid (PA) or ceramide-1 phosphate. PA has also been assigned to a density found in the TRP channel polycytin-2. Because PA is a constituent of soy polar lipids extract and has therefore been included in our purification buffer we fitted PA into the density.

We explain now our approach for fitting the respective lipids in the revised manuscript.

> 5\) The function of voltage-sensing domains in voltage-activated channels depends not only on the presence of positively charged residues in the S4, but also on the presence of countercharges along the path through which the S4 moves upon activation/deactivation, together with a hydrophobic \"plug\" that focuses the electric field at a point between the intra-and extracellular cavities in which the S4 charges reside. The figures used to illustrate the properties of the VSL-domain of Kv, TRPC4, TRPM4 and TRPV1 channels focuses only on the S4 charges. It may be useful to inspect whether the other VSL-domain helices contain comparable properties as those of voltage-activated channels.
>
> Furthermore, although it is an interesting observation that the S4 of TRPC4 is more hydrophilic than that of e.g. TRPV1, TRPM4 and TRPM8, the voltage-dependence of TRPC4 is rather weak, arguably weaker than that of TRPV1 and TRPM8. Yet, the latter channels are not expected to derive their voltage-dependence from the movement of S4. Thus, we suggest more caution in suggesting that the VSL-domain of TRPC4 might function similarly as that of voltage-gated channels. Finally, the TRPP1 channel seems to also contain a larger number of polar residues in its S4 helix, and exhibits pronounced voltage-dependence, such that it might be interesting to include it in the comparison.

As suggested by the reviewers we have now included also TRPM8 and TRPP1 in the comparison. We have also included an additional figure panel highlighting residues that provide countercharges to the basic residues in S4 and the hydrophobic patch. We have completely rephrased the paragraph describing the comparison between the VSL-domain of TRPC4 and that of voltage-gated ion channels. As suggested by the reviewers, we are now more careful in deriving a voltage-dependence from the movement of S4.
